Abstract

During the past years, the emergence of multi-drug resistance Gram-negative bacilli (MDR-GNB), including the carbapenem resistant Klebsiella pneumoniae (CRKP) has increased leading to a significant threat to public health care. Recent advanced molecular methods have improved our knowledge on how antimicrobial resistance mechanisms develop and transferred among bacterial strains. The MDR pathogens, particularly CRKP, utilize various mechanisms of resistance such as antimicrobial agent degradation, modification of antimicrobial target and alteration of cell membrane permeability. Here, the emergence of CRKP and the major antibiotic resistance mechanisms employed by CRKP will be reviewed and described. Understanding such mechanisms can be essential to develop new antimicrobial drug and help with individual treatment decisions to use alternative options to carbapenem and β-lactam antibiotics.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.